PROGENICS PHARMACEUTICALS IN

CUSIP: 743187106 Class: CMN

Rehmann Capital Advisory Group's Holding History (CIK: 0001633037)

Note: Option positions (PUT/CALL) are excluded.

Q2 2018
Shares 77 Value ($000) $619 Avg Close — Range —
Q1 2018
Shares 15 Value ($000) $0 Avg Close — Range —